Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL.

Blood - 16 Mar 2023

Simonin Mathieu, Andrieu Guillaume P, Birsen Rudy, Balsat Marie, Hypolite Guillaume, Courtois Lucien, Graux Carlos, Grardel Nathalie, Cayuela Jean-Michel, Huguet Françoise, Chalandon Yves, Le Bris Yannick, Macintyre Elizabeth, Gandemer Virginie, Petit Arnaud, Rousselot Philippe, Baruchel André, Bouscary Didier, Hermine Olivier, Boissel Nicolas, Asnafi Vahid

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child
Share to Genes, p53
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Share to Prognosis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 36599110
DOI: 10.1182/blood.2022017755

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL.PMID 36599110Read ↗

Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.Semantic proximity Read ↗

Clinical Characteristics and Outcomes of Pediatric B-Cell Acute Lymphoblastic Leukemia Harboring TP53 Mutations: A Single-Center Retrospective Study.Semantic proximity Read ↗

Prognostic impact of TP53 mutations in adult acute lymphoblastic leukemia treated with a pediatric-type regimen.Semantic proximity Read ↗

TP53 in adult acute lymphoblastic leukemia.Semantic proximity Read ↗

TP53 isoform dysregulation in pediatric B-ALL: identifying markers of favorable prognosis and relapse-associated dynamic.Semantic proximity Read ↗

T-cell acute lymphoblastic leukaemia: subtype prevalence, clinical outcome, and emerging targeted treatmentsSemantic proximity Read ↗

TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis.Semantic proximity Read ↗

TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens.Semantic proximity Read ↗

Impact of TP53 mutations and their variant allele frequency in adults with newly diagnosed acute lymphoblastic leukemia.Semantic proximity Read ↗

Novel oncogenic noncoding mutations in T-ALL.Semantic proximity Read ↗

TP53 alterations in relapsed childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.